- Global Pharma News & Resources

QIAGEN Reports Results for Third Quarter and First Nine Months of 2018

QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) announced results of operations for the third quarter and first nine months of 2018, making progress on goals set for 2018 while driving global expansion of its Sample to Insight portfolio of molecular testing solutions covering the continuum from basic research to clinical healthcare.

Please find the full press release here

View source version on

Editor Details

Last Updated: 29-Oct-2018